Manage Your Liver
Q:

More and more patients are dying of liver cancer. Change now to avoid becoming the next victim!

More and more patients are dying of liver cancer. Change now to avoid becoming the next victim!
A:

A recent report released by the US National Cancer Institute showed that among the top ten deadliest cancers, liver cancer is killing the most people. Over the past 10 years, the number of deaths caused by liver cancer has increased by 2.2% (women) and 2.8% (men) every year. The main causes for liver cancer are cirrhosis caused by hepatitis C, alcohol abuse, diabetes and obesity. [1]

 

These figures imply that in the past decade, the treatment of liver diseases is simply unsatisfactory, and the methods currently used to prevent liver cancer are also ineffective. In fact, the current treatment methods are actually increasing patients’ risk of getting liver cancer!

 

The modern approach to preventing liver cancer is to treat liver diseases that might lead to liver cancer with a variety of drugs. Other than this, there are no other commonly used preventive measures for liver cancer. But how many people have come to realise that drugs themselves are harmful to liver cells and liver function? In fact, many cases of liver cancer are caused by the excessive use of drugs. Nowadays, we are often prescribed with different drugs to treat chronic diseases, however these sorts of drugs are chemicals, use in short term it can be very effective, but use in long term, they are all likely to harm liver cells. [2]

 

In order to reduce the chance of liver cancer and lower the death rate of liver cancer in the future, we must revaluate the current approach and find better ways to treat liver diseases. The top priority and main objective in treating liver diseases should be to protect liver cells, and enhance liver function! This is the only method to ensure a healthy liver and prevent liver cancer!

Image from: www.cancer.gov

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us